Literature DB >> 3964024

Reliability and validity of the symptoms of major depressive illness.

C Mazure, J C Nelson, L H Price.   

Abstract

In two consecutive studies, we examined the interrater reliability and then the concurrent validity of interview ratings for individual symptoms of major depressive illness. The concurrent validity of symptoms was determined by assessing the degree to which symptoms observed or reported during an interview were observed in daily behavior. Results indicated that most signs and symptoms of major depression and melancholia can be reliably rated by clinicians during a semistructured interview. Ratings of observable symptoms (signs) assessed during the interview were valid indicators of dysfunction observed in daily behavior. Several but not all ratings based on patient report of symptoms were at variance with observation. These discordant patient-reported symptoms may have value as subjective reports but were not accurate descriptions of observed dysfunction.

Entities:  

Mesh:

Year:  1986        PMID: 3964024     DOI: 10.1001/archpsyc.1986.01800050053006

Source DB:  PubMed          Journal:  Arch Gen Psychiatry        ISSN: 0003-990X


  12 in total

Review 1.  Current perspectives on the genetics of unipolar depression.

Authors:  S O Moldin; T Reich; J P Rice
Journal:  Behav Genet       Date:  1991-05       Impact factor: 2.805

2.  CSF neurochemicals during tryptophan depletion in individuals with remitted depression and healthy controls.

Authors:  Francisco A Moreno; Damian Parkinson; Craig Palmer; Wm Lesley Castro; John Misiaszek; Aram El Khoury; Aleksander A Mathé; Ron Wright; Pedro L Delgado
Journal:  Eur Neuropsychopharmacol       Date:  2010-01       Impact factor: 4.600

3.  Reserpine augmentation of desipramine in refractory depression: clinical and neurobiological effects.

Authors:  L H Price; D S Charney; G R Heninger
Journal:  Psychopharmacology (Berl)       Date:  1987       Impact factor: 4.530

4.  Increased peripheral blood expression of electron transport chain genes in bipolar depression.

Authors:  Robert D Beech; Lori Lowthert; Janine J Leffert; Portia N Mason; Mary M Taylor; Sheila Umlauf; Aiping Lin; Ji Young Lee; Kathleen Maloney; Anjana Muralidharan; Boris Lorberg; Hongyu Zhao; Samuel S Newton; Shrikant Mane; C Neill Epperson; Rajita Sinha; Hilary Blumberg; Zubin Bhagwagar
Journal:  Bipolar Disord       Date:  2010-12       Impact factor: 6.744

5.  Test-retest & familial concordance of MDD symptoms.

Authors:  Ariela J E Kaiser; Carter J Funkhouser; Vijay A Mittal; Sebastian Walther; Stewart A Shankman
Journal:  Psychiatry Res       Date:  2020-07-20       Impact factor: 3.222

6.  Increased oxidative stress in patients with depression and its relationship to treatment.

Authors:  Cecilia P Chung; Dennis Schmidt; Charles Michael Stein; Jason D Morrow; Ronald M Salomon
Journal:  Psychiatry Res       Date:  2012-12-11       Impact factor: 3.222

7.  Association Study of Genotype by Depressive Response during Tryptophan Depletion in Subjects Recovered from Major Depression.

Authors:  Francisco A Moreno; Robert P Erickson; Holly A Garriock; Joel Gelernter; Jim Mintz; Jennifer Oas-Terpstra; Marilyn A Davies; Pedro L Delgado
Journal:  Mol Neuropsychiatry       Date:  2015-09-24

8.  Serotonergic function during lithium augmentation of refractory depression.

Authors:  E McCance-Katz; L H Price; D S Charney; G R Heninger
Journal:  Psychopharmacology (Berl)       Date:  1992       Impact factor: 4.530

9.  Number of risk genotypes is a risk factor for major depressive disorder: a case control study.

Authors:  Holly A Garriock; Pedro Delgado; Mitchel A Kling; Linda L Carpenter; Michael Burke; William J Burke; Thomas Schwartz; Lauren B Marangell; Mustafa Husain; Robert P Erickson; Francisco A Moreno
Journal:  Behav Brain Funct       Date:  2006-07-05       Impact factor: 3.759

10.  Increased ratio of anti-apoptotic to pro-apoptotic Bcl2 gene-family members in lithium-responders one month after treatment initiation.

Authors:  Lori Lowthert; Janine Leffert; Aiping Lin; Sheila Umlauf; Kathleen Maloney; Anjana Muralidharan; Boris Lorberg; Shrikant Mane; Hongyu Zhao; Rajita Sinha; Zubin Bhagwagar; Robert Beech
Journal:  Biol Mood Anxiety Disord       Date:  2012-09-12
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.